CD274 and neoplasm: While some studies have shown synergistic effects when combining anti-PD-L1 therapy with radiotherapy and/or temozolomide in the treatment of APRL, others, including our case, have observed that PD-L1 blockade failed to halt tumor progression despite PD-L1 positivity (85, 86).